Dr. Sahil Kumar
My Social Links

Dr. Sahil Kumar

Assistant Professor
Baddi University of Emerging Sciences and Technology, India


Highest Degree
Ph.D. in Pharmaceutical Sciences from Punjab Technical University, Jallandhar, Punjab, India

Share this Profile

Area of Interest:

Pharmacology and Toxicology
100%
Pharmaceutical Sciences
62%
Pharmaceutics
90%
Drug Designing
75%
Modeling
55%

Research Publications in Numbers

Books
0
Chapters
0
Articles
24
Abstracts
0

Selected Publications

  1. Singh, R.K., S. Sharma, A. Kaur, M. Saini and S. Kumar, 2016. Current development in multicomponent catalytic synthesis of 1,5-benzodiazepines: A systematic review. Iran. J. Catal., 6: 1-21.
    Direct Link  |  
  2. Singh, R.K., R. Bala and S. Kumar, 2016. Investigating various green chemistry techniques for an efficient synthesis of 1-amidoalkyl-2-naphthols catalyzed by zinc oxide nanoparticles under solvent-free conditions. Ind. J. Chem., 55: 381-386.
  3. Sharma, A., T. Garg, A. Aman, K. Panchal, R. Sharma, S. Kumar and T. Markandeywar, 2016. Nanogel—an advanced drug delivery tool: Current and future. Artif. Cells Nanomed. Biotechnol., 44: 165-177.
    CrossRef  |  Direct Link  |  
  4. Kumar, S., S. Goyal, M. Mukhija and R.K. Sindhu, 2016. Current approaches in targeting cancerous cells and novel anticancer drug designing. Int. J. Pharma. Prof. Res., 7: 1346-1360.
  5. Kumar, S., R.K. Singh, B. Patial, S. Goyal and T.R. Bhardwaj, 2016. Recent advances in novel heterocyclic scaffolds for the treatment of drug-resistant malaria. J. Enzyme Inhib. Med. Chem., 31: 173-186.
    Direct Link  |  
  6. Kumar, S. and A. Kumar, 2016. Synthesis and Evaluation of Novel Peroxisome Proliferator Activated Receptor-Y (PPAR-Y) Agonists for the Treatment of Diabetes. J. Toxicol., 6: 1-12.
  7. Kumar, S. and A. Kumar, 2016. Molecular Modeling and Docking Studies of Metabolites of Pioglitazone. Inventi Rapid Mol. Model., 6: 181-185.
    Direct Link  |  
  8. Kumar, S. and A. Kumar, 2016. Design, Docking, Synthesis and Antihyperglycemic Evaluation of Novel Peroxisome Proliferator Activated Receptor-Y (PPAR-Y) Agonists. Inventi Rapid Med. Chem., 4: 113-120.
    Direct Link  |  
  9. Singh, R.K., R. Bala, R. Duvedia and S. Kumar, 2015. Recent advances in one-pot multicomponent catalytic synthesis of amidoalkyl naphthols. Iran. J. Catal., 5: 187-206.
    Direct Link  |  
  10. Singh, R.K., R. Bala and S. Kumar, 2015. Microwave assisted facile synthesis of 1-amidoalkyl-2-naphthols catalyzed by stannous oxide nanoparticles. J. Ind. Chem. Soc., 92: 1161-1165.
  11. Singh, R.K., M. Saini and S. Kumar, 2015. Rapid and efficient synthesis of 1, 5-benzodiazepines promoted by stannic oxide nanoparticles under solvent-free conditions. Indian J. Heterocycl. Chem., 25: 151-156.
  12. Singh, R.K., B. Singh, R. Duvedi and S. Kumar, 2015. Sulfanilic acid: a versatile and efficient catalyst among various organocatalysts screened for the synthesis of 1-amidoalkyl-2-naphthols under solvent-free condition. Res. Chem. Intermed., 41: 4083-4099.
    CrossRef  |  Direct Link  |  
  13. Sharma, R., N. Singla, S. Kumar, T. Gaba, R.K. Rawal, H.S. Rao and T.R. Bhardwaj, 2015. Recent Advances in Polymer Drug Conjugates. Minirev. Med. Chem., 15: 751-761.
    Direct Link  |  
  14. Paramjot, N. Khan, H. Kapahi, S. Kumar, S. Arora, N. Mishra and T.R. Bhardwaj, 2015. Role of Polymer Drug Conjugates in Organ Specific delivery systems. J. Drug Targeting, 23: 387-416.
    CrossRef  |  Direct Link  |  
  15. Kumar, S., R.K. Singh, R.S.R. Murthy and T.R. Bhardwaj, 2015. Synthesis and evaluation of substituted poly(organophosphazenes) as a novel nanocarrier system for combined antimalarial therapy of primaquine and dihydroartemisinin. Pharm. Res., 32: 2736-2752.
    CrossRef  |  Direct Link  |  
  16. Kumar, S., R.K. Singh, R. Sharma, R.S.R. Murthy and T.R. Bhardwaj, 2015. Design, synthesis and evaluation of antimalarial potential of polyphosphazene linked combination therapy of primaquine and dihydroartemisinin. Eur. J. Pharmaceut. Sci., 66: 123-137.
    CrossRef  |  Direct Link  |  
  17. Arya, A., S. Kumar and R.K. Sindhu, 2015. Clinical Symptoms and Therapies for Multiple Sclerosis. J. Pharma. Technol. Res. Manage., 3: 29-47.
    Direct Link  |  
  18. Singh, R.K., S. Kumar, D.N. Prasad and T.R. Bhardwaj, 2014. Reversible redox system-based drug design, synthesis and evaluation for targeting nitrogen mustard across brain. Med. Chem. Res., 23: 2405-2416.
    CrossRef  |  Direct Link  |  
  19. Rawat, P., S. Goyal, N. Dhaliwal and S. Kumar, 2013. Therapeutic Drug Targets For Antimalarial Drug Discovery. Int. J. Res. Pharma. Biomed. Sci., 4: 1055-1059.
  20. Nirja, P. Jalwal, Sumit and S. Kumar, 2013. Recent Advances on Transdermal Drug Delivery System. Int. J. Pharma. Prof. Res., 4: 967-978.
  21. Jalwal, P., Sumit and S. Kumar, 2013. Recent Advances on Mouth Dissolving Drug Delivery System. Int. J. Pharma. Prof. Res., 4: 947-957.
  22. Goyal, S., S. Kumar, P. Rawat and N. Dhaliwal, 2013. Antifungal Activity of Calotropis Procera Towards Dermatoplatyes. Int. J. Adv. Pharm. Biol. Chem., 2: 470-472.
    Direct Link  |  
  23. Bark, H.K. Dhamija, D. Gupta, B. Parashar, S. Kumar and Shashipal, 2011. In vitro Anthelmintic Activity on Aqueous and Ethanol Extracts of Mimusops Elengi Linn. Pharmacol. Online, 3: 740-746.
  24. Kumar, A., S. Kumar, S. Jain and P. Kumar, 2010. Rosiglitazone Metabolism: A Molecular modeling study using PM6 Model. Der Pharmacia Sinica, 1: 92-104.